Skip to main content
2026 AANS Annual Scientific Meeting Main banner

    Jason S. Hauptman, MD, PhD, FAANS

    Chief and Caroline Hoeye Endowed Chair, Neurosurgery
    Barrow Neurological Institute at Phoenix Children's Hospital

    Jason Hauptman, MD, PhD, is a pediatric neurosurgeon, Caroline Hoeye Endowed Chair, and division chief of pediatric neurological surgery at the Barrow Neurological Institute at Phoenix Children's. Dr. Hauptman has highly specialized training in pediatric neurosurgery, epilepsy/functional neurosurgery and pediatric surgical neuro-oncology.

    He treats a wide range of conditions including brain tumors, epilepsy and spina bifida, as well as inherited brain and spine disorders. Dr. Hauptman is a nationally and internationally recognized expert in the use of robotic stereo-electroencephalography (sEEG), neuromodulation including deep brain stimulation (DBS) and responsive neurostimulation (RNS), awake surgery in children, laser interstitial thermal therapy (LITT) and functional hemispherectomy. He has had a longstanding academic focus on invasive and non-invasive brain mapping, the genetics of pediatric epilepsy and has led clinical trials examining novel drug therapies in children with epilepsy. He also currently serves as an investigator for the Hydrocephalus Clinical Research Network (HCRN).

    Dr. Hauptman earned his dual undergraduate degrees summa cum laude from Muhlenberg College in Allentown, Pennsylvania and completed his medical degree at Rutgers New Jersey Medical School in Newark, New Jersey. He earned his doctorate in Neuroscience at the University of California at Los Angeles (UCLA), which is where he also completed neurosurgery residency training and a specialty training and advanced research fellowship. He then completed fellowship training in pediatric neurosurgery at Children's Hospital of Pittsburgh, in Pittsburgh, Pennsylvania. Prior to joining Phoenix Children's, Dr. Hauptman was an associate professor of neurosurgery and helped to direct the surgical epilepsy program, hydrocephalus program and tuberous sclerosis complex clinic at the University of Washington and Seattle Children's Hospital from 2017 to 2024.

    Disclosure(s): Medtronic Inc: Consultant (Ongoing)

    Presentation(s):